RecruitingNCT06816381
Quantifying Uterine Elastography in Menstruating Women
Characterizing Uterine and Ovarian Tissue Stiffness Via Shear Wave Elastography in Non-Infertile, Fertile, and Infertile Women with Normal Anatomy Across the Menstrual Cycle: a Pilot Study
Sponsor
Reproductive Medicine Associates of New Jersey
Enrollment
40 participants
Start Date
Feb 6, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
This study is aiming to characterize the elasticity of the female reproductive tract including the uterus, cervix and ovary using shear wave elastography at different times during the menstrual cycle and define the standard reference range of normal uterine and ovarian elasticity. By doing so, the potential of using shear wave elastography to diagnose and predict outcomes for patients seeking fertility treatment might be established.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years
Inclusion Criteria12
- Group A
- Patients with normal menstrual cycles lasting 28-34 days
- Patients with normal uterine anatomy
- Patients with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries
- Patient who have no known infertility (i.e. women who have not tried to conceive)
- Patients with normal menstrual cycles lasting 28 days to 34 days.
- Patients with normal uterine and ovarian anatomy (absence of gross pathology on screening visit ultrasound)
- Patients with at least one prior full-term vaginal delivery with time to conception less than one year without the use of assisted reproductive technology.
- Patients with normal menstrual cycles lasting 28 days to 34 days.
- Patients with normal uterine and ovarian anatomy (absence of gross pathology on screening visit ultrasound)
- Patient with no prior pregnancy history including miscarriages, terminations, ectopic pregnancies, preterm deliveries, or full-term deliveries (i.e gravity equals zero).
- Patient with diagnosis of primary infertility, with attempted conception for at least 12 months if younger than 35 years and attempted conception for at least 6 months if 35 years or older.
Exclusion Criteria37
- BMI ≥ 35
- Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
- History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
- History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of -endometrioma)
- History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
- Currently present or surgically corrected uterine anomalies
- Ultrasound evidence of or history of communicating hydrosalpinx
- Ultrasound evidence of or history of leiomyomas
- Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
- Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
- Group B
- BMI ≥ 35
- Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
- History of cesarean section
- Patient who have no known secondary infertility (i.e. women who have not tried to conceive)
- Diagnosis of secondary infertility (i.e women who have attempted pregnancy for 12 months without success)
- History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
- History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of endometrioma)
- History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
- Currently present or surgically corrected uterine anomalies
- Ultrasound evidence of or history of communicating hydrosalpinx
- Ultrasound evidence of or history of leiomyomas
- Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
- Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
- Group C
- BMI ≥ 35
- Current use of intrauterine devices (IUDs), hormonal implants, or hormonal birth control medications. Participants on hormonal birth control interested in study participation may be included following one month of discontinuation of hormonal medication.
- History of three or more failed euploid embryo transfers
- Severe male factor infertility including severe oligozoospermia and cryptozoospermia
- History of uterine surgery (i.e hysteroscopy, dilation and curettage, myomectomy)
- History of ovarian surgery (i.e ovarian cystectomy, oophorectomy, removal of endometrioma)
- History of surgically-confirmed or clinically suspected endometriosis or ultrasound evidence of endometriosis (i.e endometrioma)
- Currently present or surgically corrected uterine anomalies
- Ultrasound evidence of or history of communicating hydrosalpinx
- Ultrasound evidence of or history of leiomyomas
- Ultrasound evidence of adenomyosis based on the Morphological Uterus Sonographic Assessment criteria (MUSA) (19)
- Ultrasound evidence of ovarian pathology including mature teratoma/dermoid cyst, persistent functional cysts larger than 2 cm, or ovarian cancer.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEShear wave elastography measurements
Shear wave elastography measurements in kilopascals via ultrasound
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06816381
Related Trials
Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility
NCT074049691 location
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT0721674216 locations
Standardization of Variable Conditions of Embryo Transfer Into the Uterine Cavity in the Procedure of Medically Assisted Procreation in Humans
NCT073961811 location
Development of an AI Platform for the Analysis of Sperm and Prediction of Their Clinical Potential
NCT074563975 locations
Cleavage-stage Versus Blastocyst-stage Embryo Transfer in IVF Patients With Few Embryos
NCT067461291 location